Keiretsu Capital, an investment fund manager focused on early-stage technology startups, closed their second co-investment fund today at $4.2 million. The new fund brings their total capital to over $10 million, from over 150 investors around the globe.
So far, the new fund has invested $850,000 in 13 early-stage life science and tech companies, and the remainder of the funds will be dispersed over the next 18 months, according to a release. The fund typically makes 2-3 investments per month following a rigorous appraisal process, said Keiretsu Capital CEO Nathan McDonald.
Keiretsu Capital invests in early stage technology companies, reducing the risk to individual investors that is normally associated with early-stage investments.